We’re looking to provide cannabis products for arthritis at an affordable price: Tilray CEO

CNBC Television published this video item, entitled “We’re looking to provide cannabis products for arthritis at an affordable price: Tilray CEO” – below is their description.

Irwin Simon, Tilray CEO, discusses his company’s launch of a medical cannabis brand called Symbios. Tilray is looking to sell medical cannabis that provides pain relief for consumers at an affordable price. He also discusses the company’s partnership with Delta.

CNBC Television YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - CNBC Television

CNBC is an American pay television business news channel, which primarily carries business day coverage of U.S. and international financial markets. Following the end of the business day and on non-trading days, CNBC primarily carries financial and business-themed documentaries and reality shows.

As of February 2015, CNBC is available to approximately 93,623,000 pay television households (80.4% of households with television) in the United States.

Recent from CNBC Television:

The narrative behind big tech is 'very strong', they are must own stocks, says laffer tengler ceo 1

The narrative behind Big Tech is ‘very strong’, they are must own stocks, says Laffer Tengler CEO

The Biden campaign can’t fix messaging around age, says Mick Mulvaney

Last Call panel weighs in on Sports Illustrated laying off entire staff

In This Story: Cannabis

Cannabis, also known as marijuana among other names, is a psychoactive drug from the Cannabis plant. Native to Central Asia and the Indian subcontinent, the cannabis plant has been used as a drug for both recreational and entheogenic purposes and in various traditional medicines for centuries.

7 Recent Items: Cannabis

Police find cannabis grow house hidden behind fridge

Grocery giant Loblaws lobbies Ontario government to change cannabis rules

Ontario’s small cannabis retailers say new government regulation could push prices higher

Dr. Sean Mackey: Tools to Reduce & Manage Pain

Cannabis stocks: What investors need to know about regulation in the U.S. market

Eswatini cannabis trade: Government considers legalising cannabis farming

Curaleaf executive chairman gives 2024 cannabis industry outlook

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.